Literature DB >> 16951986

Transforming growth factor-beta in cancer and metastasis.

Sonia B Jakowlew1.   

Abstract

Transforming growth factor-beta (TGF-beta) is a multifunctional regulatory polypeptide that is the prototypical member of a large family of cytokines that controls many aspects of cellular function, including cellular proliferation, differentiation, migration, apoptosis, adhesion, angiogenesis, immune surveillance, and survival. The actions of TGF-beta are dependent on several factors including cell type, growth conditions, and the presence of other polypeptide growth factors. One of the biological effects of TGF-beta is the inhibition of proliferation of most normal epithelial cells using an autocrine mechanism of action, and this suggests a tumor suppressor role for TGF-beta. Loss of autocrine TGF-beta activity and/or responsiveness to exogenous TGF-beta appears to provide some epithelial cells with a growth advantage leading to malignant progression. This suggests a pro-oncogenic role for TGF-beta in addition to its tumor suppressor role. During the early phase of epithelial tumorigenesis, TGF-beta inhibits primary tumor development and growth by inducing cell cycle arrest and apoptosis. In late stages of tumor progression when tumor cells become resistant to growth inhibition by TGF-beta due to inactivation of the TGF-beta signaling pathway or aberrant regulation of the cell cycle, the role of TGF-beta becomes one of tumor promotion. Resistance to TGF-beta-mediated inhibition of proliferation is frequently observed in multiple human cancers, as are various alterations in the complex TGF-beta signaling and cell cycle pathways. TGF-beta can exert effects on tumor and stromal cells as well as alter the responsiveness of tumor cells to TGF-beta to stimulate invasion, angiogenesis, and metastasis, and to inhibit immune surveillance. Because of the dual role of TGF-beta as a tumor suppressor and pro-oncogenic factor, members of the TGF-beta signaling pathway are being considered as predictive biomarkers for progressive tumorigenesis, as well as molecular targets for prevention and treatment of cancer and metastasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951986     DOI: 10.1007/s10555-006-9006-2

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  203 in total

1.  Identification of p100 target promoters by chromatin immunoprecipitation-guided ligation and selection (ChIP-GLAS).

Authors:  Xin Liu; Lijie Dong; Xuejun Zhang; Baoya Wang; Xinting Wang; Hu Li; Jinyan He; Lin Ge; Xiang Jing; Zhi Yao; Jie Yang
Journal:  Cell Mol Immunol       Date:  2010-10-04       Impact factor: 11.530

2.  TGF-beta blockade controls ascites by preventing abnormalization of lymphatic vessels in orthotopic human ovarian carcinoma models.

Authors:  Shan Liao; Jieqiong Liu; Peichun Lin; Tony Shi; Rakesh K Jain; Lei Xu
Journal:  Clin Cancer Res       Date:  2011-01-28       Impact factor: 12.531

Review 3.  Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Authors:  Jiao Zhang; Yan-Hua Chen; Qun Lu
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

4.  Proteomics profiling of Madin-Darby canine kidney plasma membranes reveals Wnt-5a involvement during oncogenic H-Ras/TGF-beta-mediated epithelial-mesenchymal transition.

Authors:  Yuan-Shou Chen; Rommel A Mathias; Suresh Mathivanan; Eugene A Kapp; Robert L Moritz; Hong-Jian Zhu; Richard J Simpson
Journal:  Mol Cell Proteomics       Date:  2010-05-28       Impact factor: 5.911

5.  Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors.

Authors:  Benjamin Diop-Frimpong; Vikash P Chauhan; Stephen Krane; Yves Boucher; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

6.  Microarray analysis of microRNA expression in skin of Xpc⁺/⁻ mice and wild-type mice.

Authors:  B Zhou; H Wu; W Li; W Liu; D Luo
Journal:  Ir J Med Sci       Date:  2010-10-26       Impact factor: 1.568

7.  Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbeta.

Authors:  Bradley Yates; Craig Zetterberg; Vaishali Rajeev; Michael Reiss; Susan R Rittling
Journal:  Exp Cell Res       Date:  2007-08-01       Impact factor: 3.905

8.  False discovery rate control for high dimensional networks of quantile associations conditioning on covariates.

Authors:  Jichun Xie; Ruosha Li
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2018-07-19       Impact factor: 4.488

9.  Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma.

Authors:  Lihua Hu; Jingpeng Liu; Zhi Li; Chunling Wang; Ali Nawshad
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-06-08

10.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.

Authors:  Sun-Mi Park; Arti B Gaur; Ernst Lengyel; Marcus E Peter
Journal:  Genes Dev       Date:  2008-04-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.